Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Congo declares its latest Ebola outbreak over, after 43 deaths - 2New movies to watch this week: See 'Marty Supreme' in theaters, rent 'Springsteen: Deliver Me from Nowhere,' stream 'Cover-Up' on Netflix
- 3An Ideal Getaway - Spots for Solo Travel
- 4As tetanus vaccination rates decline, doctors worry about rising case numbers
- 5Day to day Temporary Positions That Compensate Fairly in the US
- Must-See Public Parks from Around the Globe
- A few Up-to-date Sacks - Stylish Young ladies Shouldn't Miss
- Nitty gritty Manual for Picking Agreeable Tennis shoes
- Gym tied to outbreak of obscure disease that spreads through mist
- Netflix is releasing a documentary on Elizabeth Smart. What to know about her kidnapping, rescue and where she is now.
- From Overpowered to Coordinated: Individual Accounts of Cleaning up
- The Starbucks for Life game is back, along with your chance to win a 'Bearista' cold cup. Here's how to get your paws on one.
- Game theory explains why reasonable parents make vaccine choices that fuel outbreaks
- How did Hugh Jackman nail his latest role? Sequins, tighty-whities and embracing 'zero embarrassment.'
